Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
998
IBRX
ImmunityBio, Inc. - Common Stock
8.40 USD+1.82%+7.01%+20.00%+258.97%8.90 B USD
1019
TGTX
TG Therapeutics, Inc. - Common Stock
55.72 USD+1.25%+10.08%+1.55%+92.01%8.53 B USD
1041
SYRE
Spyre Therapeutics, Inc. - Common Stock
93.62 USD+0.01%-13.99%-5.80%+291.55%8.25 B USD
1076
RYTM
Rhythm Pharmaceuticals, Inc. - Common Stock
112.53 USD+0.59%+2.88%+4.56%+2.01%7.75 B USD

Frequently asked questions about Apogee Therapeutics, Inc. Common Stock

What is the Apogee Therapeutics, Inc. Common Stock stock price today?

The current price of Apogee Therapeutics, Inc. Common Stock (APGE) is 134.96. Over the past 24 hours, the stock has changed by +0.01%. Follow the APGE chart for real-time price dynamics.

What is the stock ticker of Apogee Therapeutics, Inc. Common Stock?

Apogee Therapeutics, Inc. Common Stock trades under the ticker APGE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Apogee Therapeutics, Inc. Common Stock stock going up?

APGE has changed by +0.11% over the last week, +0.60% over the last month, and +151.84% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Apogee Therapeutics, Inc. Common Stock?

Apogee Therapeutics, Inc. Common Stock currently has a market capitalization of 8.39 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Apogee Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Apogee Therapeutics, Inc. Common Stock reported earnings of -1.14 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Apogee Therapeutics, Inc. Common Stock net income for the last quarter?

Apogee Therapeutics, Inc. Common Stock reported net income of -85.85 M for the last quarter. The previous quarter showed -74.11 M, which means net income changed by -15.85%.

How many employees does Apogee Therapeutics, Inc. Common Stock have?

As of the latest available data, Apogee Therapeutics, Inc. Common Stock has 261 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Apogee Therapeutics, Inc. Common Stock stock?

You can buy Apogee Therapeutics, Inc. Common Stock (APGE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Apogee Therapeutics, Inc. Common Stock stock?

Investing in Apogee Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the APGE chart and related analysis on metatrader.com as part of your research.

News